-
-
-
-
-
-
-
Endologix Reports Fourth Quarter and Fiscal Year 2018 Financial Results
-
-
-
-
-
-
-
Endologix, Inc. Announces Enrollment of the First Patient in EVAS2 IDE Clinical Study of the Nellix® EndoVascular Aneurysm Sealing System
-
-
-
-
-
-
-
Endologix (ELGX) Names John Onopchenko as COO
-
-
-
-
-
-
-
After-Hours Stock Movers 02/22: (CBMX) (UCTT) (SQ) Higher; (LB) (ARRS) (TSRA) Lower (more...)
-
-
-
-
-
-
-
Endologix Reports Results for the Second Quarter 2016
-
-
-
-
-
-
-
Endologix Announces Pricing of $110 Million of Convertible Notes
-
-
-
-
-
-
-
Endologix (ELGX), TriVascular (TRIV) Enter Merger Agreement
-
1,154,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

